Vice President: Discovery Biology and Translational Research @ (January 2021 - January 2023)
Biologics Research Consultant @ Independent Consultant (January 2019 - January 2021)
Vice President Research and Scientific Founder @ Janux Therapeutics (August 2017 - August 2019)
Co Founder @ Torch Therapeutics (January 2016 - January 2017)
Executive Director @ (January 2014 - January 2016)
Vice President Research @ (January 2005 - January 2014)
Director - Discovery Biology @ Bioren (January 2004 - January 2005)
Research Scientist @ Eli Lilly and Company (January 2000 - January 2004)
Postdoctoral Fellow @ (January 1999 - January 2000)
Graduate Student @ (January 1994 - January 1999)
Senior Research Associate @ (January 1990 - January 1994)
Ramesh Bhatt Education
Stanford University School of Medicine
Ph.D. (Molecular Pharmacology)
Southern Illinois University, Carbondale
BS (Biology)
Northwestern University
Postdoctoral Fellow (Pharmacology and Biological Chemistry)
Ramesh Bhatt Skills
Animal Models
Antibodies
Assay Development
Biochemistry
Biomarkers
Biopharmaceuticals
Biotechnology
Cancer
Cancer Research
Cell
Cell Biology
Cell Culture
Drug Discovery
ELISA
Immunology
Life Sciences
Molecular Biology
Monoclonal Antibodies
Phage Display
Protein Chemistry
Protein Engineering
Protein Expression
Protein Purification
Vaccines
PowerPoint
Business Development
Strategic Planning
Strategy
Microsoft Office
Marketing
Ramesh Bhatt Summary
Ramesh Bhatt, based in California, United States, is currently a CSO and Co-Founder at Torch Therapeutics, Inc.. Ramesh Bhatt brings experience from previous roles at RevOpsis Therapeutics, JLSa2 Therapeutics, Inc., Protagonist Therapeutics and Independent Consultant. Ramesh Bhatt holds a Ph.D. in Molecular Pharmacology @ Stanford University School of Medicine. With a robust skill set that includes Animal Models, Antibodies, Assay Development, Biochemistry, Biomarkers and more. Ramesh Bhatt has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Ramesh Bhatt?
Find contact details for 700 million professionals.